m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment.

Publication Type Academic Article
Authors Cheng Y, Luo H, Izzo F, Pickering B, Nguyen D, Myers R, Schurer A, Gourkanti S, Brüning J, Vu L, Jaffrey S, Landau D, Kharas M
Journal Cell Rep
Volume 28
Issue 7
Pagination 1703-1716.e6
Date Published 08/13/2019
ISSN 2211-1247
Keywords Cell Differentiation, Cell Lineage, Hematopoiesis, Hematopoietic Stem Cells, Methyltransferases, Proto-Oncogene Proteins c-myc
Abstract Stem cells balance cellular fates through asymmetric and symmetric divisions in order to self-renew or to generate downstream progenitors. Symmetric commitment divisions in stem cells are required for rapid regeneration during tissue damage and stress. The control of symmetric commitment remains poorly defined. Using single-cell RNA sequencing (scRNA-seq) in combination with transcriptomic profiling of HSPCs (hematopoietic stem and progenitor cells) from control and m6A methyltransferase Mettl3 conditional knockout mice, we found that m6A-deficient hematopoietic stem cells (HSCs) fail to symmetrically differentiate. Dividing HSCs are expanded and are blocked in an intermediate state that molecularly and functionally resembles multipotent progenitors. Mechanistically, RNA methylation controls Myc mRNA abundance in differentiating HSCs. We identified MYC as a marker for HSC asymmetric and symmetric commitment. Overall, our results indicate that RNA methylation controls symmetric commitment and cell identity of HSCs and may provide a general mechanism for how stem cells regulate differentiation fate choice.
DOI 10.1016/j.celrep.2019.07.032
PubMed ID 31412241
PubMed Central ID PMC6818972
Back to Top